Yozova Ivayla D, Howard Judith, Henke Diana, Dirkmann Daniel, Adamik Katja N
Institute of Veterinary, Animal and Biomedical Sciences, Massey University, Private Bag 11-222, Palmerston North, 4442, New Zealand.
Clinical Diagnostic Laboratory, Department of Clinical Veterinary Medicine, Vetsuisse Faculty, University of Bern, Laenggassstrasse 124, 3012, Bern, Switzerland.
BMC Vet Res. 2017 Jun 19;13(1):185. doi: 10.1186/s12917-017-1108-2.
Hyperosmolar therapy with either mannitol or hypertonic saline (HTS) is commonly used in the treatment of intracranial hypertension (ICH). In vitro data indicate that both mannitol and HTS affect coagulation and platelet function in dogs. The aim of this study was to compare the effects of 20% mannitol and 7.2% HTS on whole blood coagulation using rotational thromboelastometry (ROTEM®) and platelet function using a platelet function analyzer (PFA®) in dogs with suspected ICH. Thirty client-owned dogs with suspected ICH needing osmotherapy were randomized to receive either 20% mannitol (5 ml/kg IV over 15 min) or 7.2% HTS (4 ml/kg IV over 5 min). ROTEM® (EXTEM® and FIBTEM® assays) and PFA® analyses (collagen/ADP cartridges) were performed before (T), as well as 5 (T), 60 (T) and 120 (T) minutes after administration of HTS or mannitol. Data at T, T and T were analyzed as a percentage of values at T for comparison between groups, and as absolute values for comparison between time points, respectively.
No significant difference was found between the groups for the percentage change of any parameter at any time point except for FIBTEM® clotting time. Within each group, no significant difference was found between time points for any parameter except for FIBTEM® clotting time in the HTS group, and EXTEM® and FIBTEM® maximum clot firmness in the mannitol group. Median ROTEM® values lay within institutional reference intervals in both groups at all time points, whereas median PFA® values were above the reference intervals at T (both groups) and T (HTS group).
Using currently recommended doses, mannitol and HTS do not differ in their effects on whole blood coagulation and platelet function in dogs with suspected ICH. Moreover, no relevant impairment of whole blood coagulation was found following treatment with either solution, whereas a short-lived impairment of platelet function was found after both solutions.
甘露醇或高渗盐水(HTS)进行的高渗疗法常用于治疗颅内高压(ICH)。体外数据表明,甘露醇和HTS均会影响犬的凝血和血小板功能。本研究的目的是使用旋转血栓弹力图(ROTEM®)比较20%甘露醇和7.2% HTS对疑似ICH犬全血凝血的影响,并使用血小板功能分析仪(PFA®)比较对血小板功能的影响。30只需要进行渗透压疗法的疑似ICH的客户自养犬被随机分为两组,分别接受20%甘露醇(5 ml/kg静脉注射,持续15分钟)或7.2% HTS(4 ml/kg静脉注射,持续5分钟)。在注射HTS或甘露醇之前(T0)以及之后5分钟(T1)、60分钟(T2)和120分钟(T3)进行ROTEM®(EXTEM®和FIBTEM®检测)和PFA®分析(胶原/ADP检测卡)。T0、T1和T2的数据分别作为T0时数值的百分比进行组间比较,作为绝对值进行时间点间比较。
除FIBTEM®凝血时间外,各时间点两组间任何参数的百分比变化均无显著差异。在每组内,除HTS组的FIBTEM®凝血时间以及甘露醇组的EXTEM®和FIBTEM®最大血凝块硬度外,各时间点任何参数均无显著差异。两组在所有时间点的ROTEM®中位数均在机构参考区间内,而PFA®中位数在T0(两组)和T1(HTS组)时高于参考区间。
使用目前推荐剂量时,甘露醇和HTS对疑似ICH犬全血凝血和血小板功能的影响无差异。此外,两种溶液治疗后均未发现全血凝血有相关损害,而两种溶液治疗后均发现血小板功能有短暂损害。